Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Vet
Pets & Animals/Pet Medications

Lilly, Eli & Co.: Micotil 300 (Tilmicosin) Injection Recalled for Missing Safety Warnings

Agency Publication Date: April 5, 2005
Share:
Sign in to monitor this recall

Summary

Lilly, Eli & Co. is recalling 4,680 bottles of Elanco brand Micotil 300 (tilmicosin phosphate) injection, a veterinary antibiotic used for livestock. The recall was initiated because the mandatory client information sheet—which contains critical warnings about the risk of death if the product is accidentally injected into humans—was missing from the packaging. Although the warning is printed on the bottle itself, the lack of the detailed information sheet increases the risk of improper handling or accidental exposure. This product was distributed to veterinary clinics and livestock supply locations in 14 states including Arizona, California, Colorado, and Texas.

Risk

If this product is accidentally injected into a human, it can cause severe cardiovascular toxicity and death. The missing information sheet contains vital safety instructions and emergency medical information required to treat human exposure.

What You Should Do

  1. Check your inventory for Elanco brand Micotil 300 Tilmicosin injection, USP (300 mg per ml) in 250 ml bottles with product code AH023038W.
  2. Verify if the package contains the required 'Client Information Sheet' which provides detailed safety warnings regarding human exposure.
  3. If the information sheet is missing, stop using the product immediately and ensure it is kept out of reach of anyone who has not been specifically trained on its dangers.
  4. Contact your veterinarian, pharmacist, or the place of purchase to obtain the missing safety documentation or to discuss returning the product for a refund.
  5. Healthcare providers or users who have questions about the recall or the missing safety information should contact Eli Lilly and Company at 1-800-545-5979.
  6. For further information or to report adverse events, contact the FDA Center for Veterinary Medicine at 1-888-FDA-VETS.

Your Remedy Options

💰Full Refund

Product return and pharmacist guidance

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Elanco brand Micotil 300 Tilmicosin injection, USP (250 ml)
Model:
AH023038W

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 31030
Status: Active
Manufacturer: Lilly, Eli & Co.
Sold By: Veterinary clinics; Livestock supply distributors
Manufactured In: United States
Units Affected: 4680 bottles
Distributed To: Arizona, California, Colorado, Illinois, Indiana, Iowa, Minnesota, Missouri, Nebraska, Pennsylvania, South Dakota, Tennessee, Texas, Wisconsin

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response